Lmcg Investments LLC Reduces Holdings in Cigna Group $CI

Lmcg Investments LLC lowered its stake in shares of Cigna Group (NYSE:CIFree Report) by 83.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,063 shares of the health services provider’s stock after selling 10,057 shares during the quarter. Lmcg Investments LLC’s holdings in Cigna Group were worth $595,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Solstein Capital LLC purchased a new position in shares of Cigna Group in the second quarter worth $29,000. Harbor Capital Advisors Inc. raised its stake in Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after acquiring an additional 49 shares during the last quarter. Chilton Capital Management LLC acquired a new stake in Cigna Group during the 2nd quarter worth about $30,000. Princeton Global Asset Management LLC grew its stake in Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 52 shares during the last quarter. Finally, Quaker Wealth Management LLC increased its holdings in shares of Cigna Group by 201.0% in the second quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock valued at $35,000 after purchasing an additional 211 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CI. Morgan Stanley reaffirmed an “overweight” rating and set a $355.00 target price on shares of Cigna Group in a report on Friday, October 31st. TD Cowen dropped their price objective on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating on the stock in a report on Tuesday, November 4th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Finally, Wells Fargo & Company lowered their price target on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $330.48.

Read Our Latest Research Report on Cigna Group

Insider Buying and Selling

In related news, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction on Monday, November 3rd. The stock was bought at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.70% of the company’s stock.

Cigna Group Stock Down 2.0%

CI stock opened at $272.29 on Monday. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. The firm’s fifty day moving average is $273.63 and its 200 day moving average is $286.84. The firm has a market cap of $72.74 billion, a PE ratio of 12.01, a P/E/G ratio of 0.96 and a beta of 0.26.

Cigna Group (NYSE:CIGet Free Report) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period last year, the firm earned $7.51 EPS. The company’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Thursday, December 4th were paid a $1.51 dividend. The ex-dividend date of this dividend was Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.